Literature DB >> 16963051

Activation of peripheral and in vivo transmigrated neutrophils in patients with stable coronary artery disease.

Josefin Paulsson1, Elham Dadfar, Claes Held, Stefan H Jacobson, Joachim Lundahl.   

Abstract

Accumulating evidence support a role of neutrophils in coronary artery disease (CAD). However little is known about the action of neutrophils at a local inflammatory site represented by an atherosclerotic plaque. To gain insight into these issues, we applied a skin blister model that permits analyses of in vivo transmigrated neutrophils. We hypothesised that the chronic inflammation in stable CAD mediates priming of neutrophils that impacts the out-come of neutrophil action at an inflammatory site. Thirteen patients with angiographically verified CAD were eligible for study entry together with 13 age and sex matched controls. Markers of inflammation (IL-6 and CRP), neutrophil activation (IL-8 and MMP-9/NGAL), and functional aspects (CD11b up-regulation and intracellular H(2)O(2) production) of peripheral and in vivo transmigrated neutrophils were studied. Systemic IL-8 and MMP-9/NGAL concentrations were significantly increased in patients indicating a primed state in circulating neutrophils. In vivo transmigrated neutrophils in stable CAD patients had an increased propensity to release MMP-9/NGAL and a reduced capacity to up-regulate CD11b and to produce hydrogen peroxide. These aberrations at the inflammatory site may be a consequence of a primed state of circulating neutrophils and point towards potential mechanisms whereby neutrophils at a local inflammatory site may contribute to the pathogenesis of CAD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963051     DOI: 10.1016/j.atherosclerosis.2006.08.003

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  20 in total

1.  The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.

Authors:  I Lambrinoudaki; M Karaflou; G Kaparos; O Grigoriou; A Alexandrou; C Panoulis; E Logothetis; M Creatsa; G Christodoulakos; E Kouskouni
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

2.  Neutrophil gelatinase-associated lipocalin levels associated with cardiovascular disease in chronic kidney disease patients.

Authors:  Fumihiko Furuya; Hiroki Shimura; Hiroshi Yokomichi; Kazuya Takahashi; Daiichiro Akiyama; Chikako Asakawa; Ayako Okamura; Ai Motosugi; Kazutaka Haraguchi; Zentaro Yamagata; Tetsuro Kobayashi
Journal:  Clin Exp Nephrol       Date:  2013-12-12       Impact factor: 2.801

Review 3.  Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.

Authors:  Yu Wang
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

4.  Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.

Authors:  Xeni Provatopoulou; Antonia Gounaris; Eleni Kalogera; Flora Zagouri; Ioannis Flessas; Evgenios Goussetis; Afroditi Nonni; Ioannis Papassotiriou; George Zografos
Journal:  BMC Cancer       Date:  2009-11-04       Impact factor: 4.430

Review 5.  Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.

Authors:  Helen Vosper
Journal:  Br J Pharmacol       Date:  2009-07-20       Impact factor: 8.739

6.  Quantum dot mediated imaging of atherosclerosis.

Authors:  Ashwath Jayagopal; Yan Ru Su; John L Blakemore; MacRae F Linton; Sergio Fazio; Frederick R Haselton
Journal:  Nanotechnology       Date:  2009-03-31       Impact factor: 3.874

7.  Chronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin.

Authors:  Alfonso Eirin; Monika L Gloviczki; Hui Tang; Andrew D Rule; John R Woollard; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Nephrol Dial Transplant       Date:  2012-08-23       Impact factor: 5.992

Review 8.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

9.  In vivo transmigrated monocytes from patients with stable coronary artery disease have a reduced expression of CD11b.

Authors:  J M Paulsson; E Dadfar; C Held; S H Jacobson; J Lundahl
Journal:  Clin Exp Immunol       Date:  2008-05-05       Impact factor: 4.330

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.